Genomma Lab Internacional, S.A.B. de C.V.

Mexico Stock Exchange LABB.MX

Genomma Lab Internacional, S.A.B. de C.V. Net Income Margin for the year ending December 31, 2023: 6.59%

Genomma Lab Internacional, S.A.B. de C.V. Net Income Margin is 6.59% for the year ending December 31, 2023, a -20.23% change year over year. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.

Genomma Lab Internacional, S.A.B. de C.V. Net Income Margin for the year ending December 31, 2022 was 8.26%, a -2.20% change year over year.
Genomma Lab Internacional, S.A.B. de C.V. Net Income Margin for the year ending December 31, 2021 was 8.44%, a -16.54% change year over year.
Genomma Lab Internacional, S.A.B. de C.V. Net Income Margin for the year ending December 31, 2020 was 10.12%, a 68.28% change year over year.
Genomma Lab Internacional, S.A.B. de C.V. Net Income Margin for the year ending December 31, 2019 was 6.01%, a -36.07% change year over year.

Key data

Date	Net Income Margin	EBITDA Margin	EBIT Margin	EBITDA

Mexico Stock Exchange: LABB.MX

Genomma Lab Internacional, S.A.B. de C.V.

CEO	Mr. Juan Marco Sparvieri
IPO Date	June 18, 2008
Location	Mexico
Headquarters	Av. Antonio Dovalí Jaime no.70
Employees	1,633
Sector	Consumers Staples
Industries Personal Care Cleaning Supplies Consumer Packaged Goods Cosmetics Drugstores & Retail Pharmacies Eyewear Pharmaceuticals Tobacco

Description

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico and internationally. It provides skin care, health and wellness, hair care, pain relief, cough and cold, gastro, sexual health, antiperspirant deodorant, hand sanitizer, isotonic deink, and razor products, as well as analgesics, antifungals, and hemorrhoids. The company offers its products under the Cicatricure, Asepxia, Teatrical, Goicoechea, Sistema GB, Medicasp, Tío Nacho, Vanart, Novamil, Ultra Bengue, X-Ray, Tafirol, Alliviax, Bufferin, Next, XL-3, Genoprazol, QG5, Kaopectate, Proctan, Nikzon, Unesia, Silka Medic, lagicam, Suerox, Groomen, DiabetTX, and other brands. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.

Key trends

Past 5 years